Page last updated: 2024-10-27

berotek and Premenstrual Syndrome

berotek has been researched along with Premenstrual Syndrome in 1 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goriachkina, LA1
Nenasheva, NM1
Puzhko, SG1
Dauletbaev, NB1
Dotsenko, VL1
Nonikov, DV1

Trials

1 trial available for berotek and Premenstrual Syndrome

ArticleYear
[A trial of the use of ditek in the clinical picture of allergic diseases].
    Terapevticheskii arkhiv, 1994, Volume: 66, Issue:3

    Topics: Adult; Aerosols; Asthma; Bronchodilator Agents; Cromolyn Sodium; Drug Combinations; Female; Fenotero

1994